Serum FGF23 and Risk of Cardiovascular Events in Relation to Mineral Metabolism and Cardiovascular Pathology | Zendy

Johan Ärnlöv | Zendy; Axel C. Carlsson | Zendy; Johan Sundström | Zendy; Erik Ingelsson | Zendy; Anders Larsson | Zendy; Lars Lind | Zendy; Tobias E. Larsson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum FGF23 and Risk of Cardiovascular Events in Relation to Mineral Metabolism and Cardiovascular Pathology

Author(s) -

Johan Ärnlöv,

Axel C. Carlsson,

Johan Sundström,

Erik Ingelsson,

Anders Larsson,

Lars Lind,

Tobias E. Larsson

Publication year - 2013

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.09570912

Subject(s) - medicine , odds ratio , prospective cohort study , risk factor , fibroblast growth factor 23 , confounding , parathyroid hormone , myocardial infarction , confidence interval , subclinical infection , endocrinology , cardiology , logistic regression , arterial stiffness , blood pressure , calcium

Circulating fibroblast growth factor-23 is associated with adverse cardiovascular outcomes in CKD and non-CKD individuals, but the underlying mechanism remains unclear. This study tested whether this association is independent of mineral metabolism and indices of subclinical cardiovascular pathology.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research